mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0024 |
1 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0018 |
1 |
mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
0.0013 |
1 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00082 |
1 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
1 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00092 |
1 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
-0.00084 |
1 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.00086 |
1 |
mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
0.00074 |
1 |
mRNA |
NSC-87877 |
GDSC1000 |
pan-cancer |
AAC |
-0.00069 |
1 |